Moderna wins FDA approval for Covid shot in at-risk kids; Makary, Prasad defend vaccine framework
The FDA on Thursday approved Moderna’s Covid-19 shot for kids six months through 11 years old who are at higher risk of severe disease, the latest move that fits within the agency’s new vaccine framework.